Descriptor English: | 17 alpha-Hydroxyprogesterone Caproate | ||||||
Descriptor Spanish: |
Caproato de 17 alfa-Hidroxiprogesterona
| ||||||
Descriptor Portuguese: | Caproato de 17 alfa-Hidroxiprogesterona | ||||||
Descriptor French: | Caproate d'hydroxyprogestérone | ||||||
Entry term(s): |
17 Hydroxyprogesterone Capronate 17 alpha Hydroxy Progesterone Caproate 17 alpha Hydroxyprogesterone Caproate 17 alpha Oxyprogesterone Capronate 17 alpha-Oxyprogesterone Capronate 17-Hydroxyprogesterone Capronate 17-alpha-Hydroxy-Progesterone Caproate Caproate, 17-alpha-Hydroxy-Progesterone Delalutin Hydroxyprogesterone Caproate Hydroxyprogesterone Hexanoate Makena Neolutin Oxyprogesterone Caproate Prolutin Depot Proluton Depot |
||||||
Tree number(s): |
D04.210.500.745.745.654.829.395.400.500 D06.472.334.851.687.750.478.400.250 |
||||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D000077713 | ||||||
Scope note: | Hydroxyprogesterone derivative that acts as a PROGESTIN and is used to reduce the risk of recurrent MISCARRIAGE and of PREMATURE BIRTH. It is also used in combination with ESTROGEN in the management of MENSTRUATION DISORDERS. |
||||||
Allowable Qualifiers: |
AA analogs & derivatives AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis EC economics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||||
Pharm Action: |
Estrogen Antagonists Progestins |
||||||
Registry Number: | 276F2O42F5 | ||||||
CAS Type 1 Name: | Hexanoic acid, 3,20-dioxopregn-4-en-17-yl ester | ||||||
Public MeSH Note: | 2019;see 17-ALPHA-HYDROXY-PROGESTERONE CAPROATE 2003-2018; 17-ALPHA-HYDROXYPROGESTERONE CAPROATE was indexed under HYDROXYPROGESTERONES 1979-2018 |
||||||
History Note: | 2019 (1979) |
||||||
DeCS ID: | 57727 | ||||||
Unique ID: | D000077713 | ||||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
Date Established: | 2019/01/01 | ||||||
Date of Entry: | 2018/07/09 | ||||||
Revision Date: | 2018/04/09 |
-
-
CHEMICALS AND DRUGS
Polycyclic Compounds [D04]Polycyclic Compounds
|
17 alpha-Hydroxyprogesterone Caproate
- Preferred
Prolutin Depot
- Narrower
Neolutin
- Narrower
Makena
- Narrower
Delalutin
- Narrower
Concept UI |
M0074009 |
Scope note | Hydroxyprogesterone derivative that acts as a PROGESTIN and is used to reduce the risk of recurrent MISCARRIAGE and of PREMATURE BIRTH. It is also used in combination with ESTROGEN in the management of MENSTRUATION DISORDERS. |
Preferred term | 17 alpha-Hydroxyprogesterone Caproate |
Entry term(s) |
17 Hydroxyprogesterone Capronate 17 alpha Hydroxy Progesterone Caproate 17 alpha Hydroxyprogesterone Caproate 17 alpha Oxyprogesterone Capronate 17 alpha-Oxyprogesterone Capronate 17-Hydroxyprogesterone Capronate 17-alpha-Hydroxy-Progesterone Caproate Caproate, 17-alpha-Hydroxy-Progesterone Hydroxyprogesterone Caproate Hydroxyprogesterone Hexanoate Oxyprogesterone Caproate |
Concept UI |
M0074007 |
Preferred term | Prolutin Depot |
Entry term(s) |
Proluton Depot |
Concept UI |
M0074005 |
Preferred term | Neolutin |
Concept UI |
M0559506 |
Preferred term | Makena |
Concept UI |
M0074002 |
Preferred term | Delalutin |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey